We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$306M
AUM Growth
-$6.25M
Cap. Flow
+$6.8M
Cap. Flow %
2.22%
Top 10 Hldgs %
51.08%
Holding
39
New
6
Increased
12
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$16.1M
2
TMO icon
Thermo Fisher Scientific
TMO
+$10.7M
3
AVTR icon
Avantor
AVTR
+$5.1M
4
LH icon
Labcorp
LH
+$4.74M
5
BIIB icon
Biogen
BIIB
+$3.99M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$16.3M
2
EW icon
Edwards Lifesciences
EW
+$6.04M
3
THC icon
Tenet Healthcare
THC
+$4.59M
4
AMGN icon
Amgen
AMGN
+$4.25M
5
ELV icon
Elevance Health
ELV
+$4.02M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$143B
$22.3M 7.29%
920,000
-5,000
-0.5% -$117K
MDT icon
2
Medtronic
MDT
$106B
$19.5M 6.38%
224,000
+19,000
+9% +$1.61M
BMY icon
3
Bristol-Myers Squibb
BMY
$124B
$18.8M 6.14%
406,000
-29,000
-7% -$1.42M
BDX icon
4
Becton Dickinson
BDX
$43.6B
$16.9M 5.52%
98,000
+16,000
+20% +$2.93M
MRK icon
5
Merck
MRK
$315B
$16M 5.23%
+202,000
New +$16.1M
GILD icon
6
Gilead Sciences
GILD
$167B
$14.1M 4.6%
127,000
-13,000
-9% -$1.38M
INCY icon
7
Incyte
INCY
$23.4B
$13.9M 4.54%
204,000
+45,000
+28% +$2.85M
AMGN icon
8
Amgen
AMGN
$198B
$12.3M 4.02%
44,000
-15,000
-25% -$4.25M
IONS icon
9
Ionis Pharmaceuticals
IONS
$8.99B
$11.3M 3.69%
285,842
– –
CVS icon
10
CVS Health
CVS
$137B
$11.2M 3.68%
163,000
-39,000
-19% -$2.56M
CAH icon
11
Cardinal Health
CAH
$53.5B
$11.1M 3.62%
66,000
-22,000
-25% -$3.27M
TMO icon
12
Thermo Fisher Scientific
TMO
$198B
$10.3M 3.38%
+25,500
New +$10.7M
CNC icon
13
Centene
CNC
$32.8B
$8.25M 2.7%
152,000
-25,000
-14% -$1.47M
BAX icon
14
Baxter International
BAX
$11.7B
$8.12M 2.65%
268,007
+20,357
+8% +$617K
ZBH icon
15
Zimmer Biomet
ZBH
$17.6B
$8.08M 2.64%
88,631
-25,000
-22% -$2.42M
BRKR icon
16
Bruker
BRKR
$8.86B
$8.07M 2.64%
195,970
-16,000
-8% -$618K
ELV icon
17
Elevance Health
ELV
$80.9B
$7.3M 2.39%
18,779
-10,000
-35% -$4.02M
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.5B
$6.73M 2.2%
122,348
-15,000
-11% -$883K
BIIB icon
19
Biogen
BIIB
$30.4B
$6.36M 2.08%
50,639
+32,000
+172% +$3.99M
HUM icon
20
Humana
HUM
$48B
$5.75M 1.88%
23,500
-1,500
-6% -$374K
QGEN icon
21
Qiagen
QGEN
$8.49B
$5.62M 1.84%
117,000
-70,000
-37% -$3.04M
GEHC icon
22
GE HealthCare
GEHC
$28.7B
$5.48M 1.79%
74,000
+12,000
+19% +$835K
LH icon
23
Labcorp
LH
$23.2B
$5.11M 1.67%
+19,484
New +$4.74M
AVTR icon
24
Avantor
AVTR
$7.56B
$5.02M 1.64%
+372,638
New +$5.1M
PTCT icon
25
PTC Therapeutics
PTCT
$6.52B
$4.51M 1.47%
92,250
– –
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2025 Portfolio in Review

As of Q2 2025, Sector Gamma AS held 39 positions worth $306M, down 2% from $312M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sector Gamma AS's Q2 2025 filing shows 6 new, 12 increased, 17 reduced and 1 closed positions. Its largest new stake was Merck: 202,000 shares worth $16M. The largest sale was Johnson & Johnson, an estimated $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q2 2025 buy was Merck: 202,000 shares worth $16M.
  • Sector Gamma AS added most to Biogen in Q2 2025, an estimated $3.99M increase.
  • Sector Gamma AS's biggest Q2 2025 reduction was Edwards Lifesciences, cutting an estimated $6.04M.
  • Sector Gamma AS fully exited Johnson & Johnson in Q2 2025, selling an estimated $16.3M.
  • Sector Gamma AS's ten largest holdings make up 51% of its $306M portfolio in Q2 2025.
  • Sector Gamma AS opened 6 new positions and closed 1 in Q2 2025.
  • Sector Gamma AS's portfolio value fell 2% quarter-over-quarter to $306M.

Based on Sector Gamma AS's 13F filing for Q2 2025, filed 31 Jul 2025.